Nightingale Health Signs $6.5M Proteomics Deal With Michael J. Fox Foundation
Nightingale Health Plc has signed a $6.5 million services agreement with the Michael J. Fox Foundation to perform proteomics on 60,000 UK Biobank samples. The analysis will utilize Alamar's NULISAseq Neuro 220 Panel, and the resulting dataset will be provided to UK Biobank for research purposes.